VP​/Deputy Head, M&A Transactions

Job Description Summary

Location:

this role can be based in Cambridge MA, or East Hanover NJ US, or Basel Switzerland. If based in Europe please apply to REQ-.

The Novartis Corporate & Business Development team is seeking a new VP, M&A Transactions. This leader will be fully responsible and accountable for end-to-end execution of deals with a focus on large (>$2 billion MAL value) scale acquisitions and divestments  VP, M&A Transactions has final accountability for the assessment and execution of acquisition opportunities at Novartis to secure external innovation and drive Novartis future revenue growth through leading cross-functional teams to inform material capital allocation decisions.

• Deal strategy and execution
  • Once an opportunity has been identified and triage is completed by S&E (Search & Evaluation), the VP, M&A Transactions will outline a deal strategy (game plan), including a timeline to signing, governance planning, gating diligence items, bidding strategy, and an engagement plan with the target company.
  • Shape and secure non-binding offer and ultimately binding offer terms in collaboration with M&A Finance, DD (Due Diligence), M&A Legal, M&A Tax, and other relevant line functions within Biomedical Research (BR), Development, TAS, US and International as needed.
  • Build and manage high-performing teams on a deal-by-deal basis, ensuring appropriate level of seniority and cross-functional representation to enable consistently high-quality decision-making at Executive Committee of Novartis (ECN) and Board of Directors (BoD) level.
• Risk and value assessment
  • In collaboration with DD head, launch and govern a VDR (Virtual Data Room) based diligence, ensuring target company is disclosing all relevant information and Novartis internal experts are reviewing all relevant information. While the DD head will lead scientific and technical diligence, the VP / Deputy Head M&A Transactions will lead all aspects of corporate diligence.
  • Coordinate relevant business case inputs and ensure appropriate review from relevant TAL (Therapy Area Leadership) members and ECN members.
  • Incorporate findings from diligence into the risk and value assessment and solicit support from third parties in the diligence process as needed to inform the assessment and recommendation.
• Review and negotiation of definitive documentation
  • Primary counterpart to M&A legal to solicit business input on transaction documents.
  • Soliciting input across functions and ensuring transaction documents secure Novartis interests while balancing risk and reward for the partner.
• Governance orchestration
  • Prepare decision-making framework for ECN DC and BoD, ensuring consistent approach to risk and value assessment of an opportunity.
  • Choreograph compressed / ad-hoc governance calendars to secure approvals in competitive processes and maintain pre-read hygiene.
  • Integrate PSB, R&D LT, and Commercial Review session outputs into ECN DC and BoD materials.
• Approval-to-closing diligence process
  • In collaboration with DD Head. review of all new information shared by the counter party or as it relates to the target asset(s) profile from approval until signing and again from signing until closing.
  • In collaboration with DD Head Ensure all new information is adequately reviewed by relevant line functions with escalation to C&B D management and relevant ECN members as appropriate.
  • Key partner to integration function post-signing to ensure knowledge transfer and strategic value drivers of the deal are prioritized in the integration planning process.
• Team development
  • Develop strategic, content, and execution capabilities of more junior M&A Transactions leads (responsible for smaller scale deals) through regular coaching and feedback.
  • Model M&A team best practices to enhance overall organizational effectiveness in executing external innovation opportunities.
• Late-stage Landscaping
  • Lead TA landscaping exercises for late-stage opportunities through collaboration with S&E and TA strategy groups.
  • Prepare comprehensive market and deal dynamic assessments on an annual or bi-annual basis to inform strategic decision-making on capital allocation strategy and…